4
Changes in Ownership
ENANTA PHARMACEUTICALS INC Filed Acc 0001062993-24-020375
President and CEO sold 5,142 shares at $8.06 ($41,445)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Luly Jay R. President and CEO | 2024-12-06 | Sale 10b5-1 | −5,142 | $8.06 | $41,445 | 801,638 | D |
| Open-market sales · 5,142 sh · avg $8.06 · $41,445 | |||||||
Loading xslF345X05/form4.xml…